Mackay A R, Hartzler J L, Pelina M D, Thorgeirsson U P
Division of Cancer Etiology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.
J Biol Chem. 1990 Dec 15;265(35):21929-34.
Two major gelatinolytic metalloproteinases (gelatinases) of 65 kDa and 92 kDa were purified from a tumor cell line. Analysis of collagen degradation showed that native full-length Engelbreth-Holm-Swarm (EHS) type IV collagen was not cleaved by the purified gelatinases under conditions where native pepsin-extracted human placental type IV and V collagen and heat-denatured collagens were markedly degraded. However, EHS type IV collagen degradation was noted at 37 degrees C, i.e., under conditions that would favor denaturation of the collagen molecule in solution. The pattern of degradation of human placental type IV and V collagen appeared similar for both gelatinases. Zymogram analysis of gelatinase activity in the absence of sodium dodecyl sulfate (SDS) (to eliminate possible SDS-mediated denaturation of type IV collagen) confirmed the inability of 65 and 92-kDa gelatinases to degrade native full-length EHS type IV collagen. Under the same conditions and in SDS-polyacrylamide gel electrophoresis zymograms the gelatinases degraded pepsin-predigested EHS type IV collagen and pepsin-extracted human placental type IV collagen. These data suggest that the 65- and 92-kDa tumor cell gelatinases are not true type IV collagenases. Their ability to degrade pepsin-solubilized, or denatured, type IV collagen suggests a specificity for telopeptide precleaved or conformationally altered forms of this molecule.
从一种肿瘤细胞系中纯化出了两种主要的明胶分解性金属蛋白酶(明胶酶),分子量分别为65 kDa和92 kDa。胶原降解分析表明,在天然胃蛋白酶提取的人胎盘IV型和V型胶原以及热变性胶原被显著降解的条件下,纯化的明胶酶并未切割天然全长的恩格尔布雷特 - 霍尔姆 - 斯旺(EHS)IV型胶原。然而,在37摄氏度时,即有利于溶液中胶原分子变性的条件下,观察到了EHS IV型胶原的降解。两种明胶酶对人胎盘IV型和V型胶原的降解模式似乎相似。在不存在十二烷基硫酸钠(SDS)(以消除SDS介导的IV型胶原可能的变性)的情况下对明胶酶活性进行的酶谱分析证实,65 kDa和92 kDa的明胶酶无法降解天然全长的EHS IV型胶原。在相同条件下,在SDS - 聚丙烯酰胺凝胶电泳酶谱中,明胶酶降解了胃蛋白酶预消化的EHS IV型胶原和胃蛋白酶提取的人胎盘IV型胶原。这些数据表明,65 kDa和92 kDa的肿瘤细胞明胶酶并非真正的IV型胶原酶。它们降解胃蛋白酶可溶解的或变性的IV型胶原的能力表明,它们对该分子的端肽预先切割或构象改变的形式具有特异性。